FindTrial
Sign In

The role and molecular mechanism of ARHGAP30 in cervical cancer

The role and molecular mechanism of ARHGAP30 in cervical cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016370
Enrollment
Unknown
Registered
2018-05-28
Start date
2018-06-01
Completion date
Unknown
Last updated
2018-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Interventions

cancer,adjacent cancer:None

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Cervical cancer

Exclusion criteria

Exclusion criteria: cervical intraepithelial neoplasia, Benign disease of the cervix

Design outcomes

Primary

MeasureTime frame
Expression of ARHGAP30;—

Countries

China

Contacts

Public ContactZhihong Ai

Shanghai Sixth People's Hospital

ai_zhihong@126.com+86 18930172733

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026